445 related articles for article (PubMed ID: 10416042)
1. Coenzyme Q10 treatment in serious heart failure.
Munkholm H; Hansen HH; Rasmussen K
Biofactors; 1999; 9(2-4):285-9. PubMed ID: 10416042
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment.
Morisco C; Nappi A; Argenziano L; Sarno D; Fonatana D; Imbriaco M; Nicolai E; Romano M; Rosiello G; Cuocolo A
Mol Aspects Med; 1994; 15 Suppl():s155-63. PubMed ID: 7752827
[TBL] [Abstract][Full Text] [Related]
3. The clinical and hemodynamic effects of coenzyme Q10 in congestive cardiomyopathy.
Sacher HL; Sacher ML; Landau SW; Kersten R; Dooley F; Sacher A; Sacher M; Dietrick K; Ichkhan K
Am J Ther; 1997; 4(2-3):66-72. PubMed ID: 10423594
[TBL] [Abstract][Full Text] [Related]
4. The effect of coenzyme Q10 in patients with congestive heart failure.
Khatta M; Alexander BS; Krichten CM; Fisher ML; Freudenberger R; Robinson SW; Gottlieb SS
Ann Intern Med; 2000 Apr; 132(8):636-40. PubMed ID: 10766682
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials.
Lei L; Liu Y
BMC Cardiovasc Disord; 2017 Jul; 17(1):196. PubMed ID: 28738783
[TBL] [Abstract][Full Text] [Related]
6. [Coenzyme Q10: contractile dysfunction of the myocardial cell and metabolic therapy].
Davini A; Cellerini F; Topi PL
Minerva Cardioangiol; 1992 Nov; 40(11):449-53. PubMed ID: 1291925
[TBL] [Abstract][Full Text] [Related]
7. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
Waagstein F; Strömblad O; Andersson B; Böhm M; Darius M; Delius W; Goss F; Osterziel KJ; Sigmund M; Trenkwalder SP; Wahlqvist I
Eur J Heart Fail; 2003 Oct; 5(5):679-91. PubMed ID: 14607208
[TBL] [Abstract][Full Text] [Related]
8. Coenzyme Q10 as an adjunctive therapy in patients with congestive heart failure.
Mortensen SA
J Am Coll Cardiol; 2000 Jul; 36(1):304-5. PubMed ID: 10898453
[No Abstract] [Full Text] [Related]
9. The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children.
Soongswang J; Sangtawesin C; Durongpisitkul K; Laohaprasitiporn D; Nana A; Punlee K; Kangkagate C
Pediatr Cardiol; 2005; 26(4):361-6. PubMed ID: 16374685
[TBL] [Abstract][Full Text] [Related]
10. [Prophylaxis of ischemic heart lesions during chronic heart failure with complex therapy using Q10 coenzyme].
Shilov AM; Mel'nik MV; Voevodina ES; Osiia AO; Griaznov DA
Anesteziol Reanimatol; 2011; (2):34-8. PubMed ID: 21692219
[TBL] [Abstract][Full Text] [Related]
11. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group.
Hofman-Bang C; Rehnqvist N; Swedberg K; Wiklund I; Aström H
J Card Fail; 1995 Mar; 1(2):101-7. PubMed ID: 9420639
[TBL] [Abstract][Full Text] [Related]
12. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study.
Morisco C; Trimarco B; Condorelli M
Clin Investig; 1993; 71(8 Suppl):S134-6. PubMed ID: 8241697
[TBL] [Abstract][Full Text] [Related]
13. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials.
Soja AM; Mortensen SA
Mol Aspects Med; 1997; 18 Suppl():S159-68. PubMed ID: 9266518
[TBL] [Abstract][Full Text] [Related]
14. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of taurine in chronic congestive heart failure and its prospective application.
Azuma J; Sawamura A; Awata N
Jpn Circ J; 1992 Jan; 56(1):95-9. PubMed ID: 1538580
[TBL] [Abstract][Full Text] [Related]
16. [Lack of effectiveness of coenzyme Q10 (ubiquinone) in long-term treatment of dilated cardiomyopathy].
Permanetter B; Rössy W; Weingartner F; Bauer R; Seidl KF; Klein G
Z Kardiol; 1989 Jun; 78(6):360-5. PubMed ID: 2667265
[TBL] [Abstract][Full Text] [Related]
17. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
Gilbert EM; Anderson JL; Deitchman D; Yanowitz FG; O'Connell JB; Renlund DG; Bartholomew M; Mealey PC; Larrabee P; Bristow MR
Am J Med; 1990 Mar; 88(3):223-9. PubMed ID: 1968710
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of chronic cardiac insufficiency with coenzyme Q10, results of meta-analysis in controlled clinical trials].
Soja AM; Mortensen SA
Ugeskr Laeger; 1997 Dec; 159(49):7302-8. PubMed ID: 9417729
[TBL] [Abstract][Full Text] [Related]
19. Effects of low-dose flosequinan on left ventricular systolic and diastolic chamber performance.
Starling MR
Am Heart J; 1994 Jul; 128(1):124-33. PubMed ID: 8017265
[TBL] [Abstract][Full Text] [Related]
20. [Coenzyme Q10 (ubiquinone) in the treatment of heart failure. Are any positive effects documented?].
Spigset O
Tidsskr Nor Laegeforen; 1994 Mar; 114(8):939-42. PubMed ID: 8191473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
